Prior to becoming a privately-held entity via an acquisition by the executive management team in September of 2013, N2 Biomedical operated under the name Spire Biomedical Inc., a wholly-owned subsidiary of Spire Corporation. The company is an innovator in ion beam technology with a 30-year history of successfully providing services to the medical device industry.
N2 Biomedical currently processes over 500,000 medical devices per year for leading orthopedic, cardiovascular and dental companies. However, our vast technical experience in surface treatment and coating technologies, coupled with our fully-equipped state-of-the-art processing facilities, allow us to serve the needs of numerous clients from non-medical fields as well, including aerospace, automotive, and defense and consumer electronics.
N2 Biomedical is ISO-13485 certified and FDA GMP-compliant. We operate in a 27,000 square foot facility housing office, laboratory, manufacturing, and cleanroom space to service all customer and regulatory requirements. We are frequently audited by our customers, maintaining greater than 99.7% process yield with robust and evolved systems for control of processes.